Clinical trials: Burning Mouth Syndrome
Caffeine, Burning Mouth Syndrome
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
The aim of this study was to evaluate the efficacy of caffeine and alpha-lipoic acid in the treatment of burning mouth syndrome by symptom assessment with visual analogue scale.
- Trial name
- NCT06195137
- Testing
- Caffeine, Alpha Lipoic Acid
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Lu Jiang
Burning Sore Mouth
Alpha Lipoic Acid for Burning Mouth
Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.
- Trial name
- NCT00387543
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Mayo Clinic
Burning Mouth Syndrome
Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
Burning mouth syndrome (BMS) is a condition that affects the oral mucosa; this is seen mainly in postmenopausal women. The intensity of burning and its clinical manifestations may be variable between patients.
- Trial name
- BurnLasCLo (NCT04313907)
- Testing
- low level laser therapy plus topical clonazepam
- Where
- Mexico
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Universidad Nacional Autonoma de Mexico
Burning Mouth Syndrome
Reducing Patient Memory Recall in the Burning Mouth Patient Population
The goal of this study is to learn about burning mouth syndrome symptoms in real time in patients with burning mouth syndrome. The main questions it aims to answer are: (1) To test the ability of a smartphone app to collect…
- Trial name
- NCT05819697
- Testing
- FIRE Trial/Track Your Happiness notifications
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Pennsylvania
Burning Mouth Syndrome, Quality of Life
Effect to the Photobiomodulation in the Burning Mouth Syndrome
Introduction: Burning mouth syndrome (BMS) is a pathology with a low prevalence, affecting between 0.1% and 3.7% of the general population, the ratio between women and men is between 3 and 7:1.
- Conditions
- Burning Mouth Syndrome, Quality of Life, Anxiety Depression, Dry Mouth
- Trial name
- PBM-BMS (NCT05871580)
- Testing
- Low frequency laser activated photobiomodulation, Low frequency laser photobiomodulation inactive
- Where
- Spain
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Santiago de Compostela
Burning Mouth Syndrome
The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
The purpose of this study was to examine the efficacy of N-acetyl cysteine in the treatment of burning mouth syndrome. A control group of patients with burning mouth syndrome will receive a placebo.
- Trial name
- NCT05309070
- Testing
- N-acetyl cysteine
- Where
- Croatia
- Volunteers
- 80 people
- Sponsor
- University of Zagreb
Fibromyalgia, Irritable Bowel Syndrome
Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
Objectives : To investigate the analgesic effects of repeated sessions of unilateral rTMS in patients with chronic pain syndrome due to fibromyalgia, IBS or burning mouth syndrome. Primary outcome will be numerical pain scores.
- Conditions
- Fibromyalgia, Irritable Bowel Syndrome, Burning Mouth Syndrome
- Trial name
- NCT00374673
- Testing
- Repetitive transcranial magnetic stimulation
- Where
- France
- Volunteers
- 60 people
- Sponsor
- Hospital Ambroise Paré Paris
Temporomandibular Joint Dysfunction Syndrome, Burning Mouth Syndrome
Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
Patients with chronic masticatory muscle pain (i.e., pain greater than three months) or patients with burning mouth syndrome participate in this study.
- Trial name
- NCT00716807
- Testing
- nalbuphine plus naloxone
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- University of California, San Francisco
Burning Mouth Syndrome
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
Burning Mouth Syndrome (BMS) is a chronic pain disorder that presents with inflammation and burning sensation in the oral cavity without visible lesions.
- Trial name
- burningmouth (NCT06217731)
- Testing
- Laser+clonazepam, Laser, Clonazepam
- Where
- Spain
- Volunteers
- 20 people
- Sponsor
- Universidad de Murcia
Burning Mouth Syndrome
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables.
- Trial name
- NCT05729529
- Testing
- Lipoid acid gel
- Where
- Italy
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Catania
Atrophic Glossitis, Burning Mouth Syndrome
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Patients with atrophic glossitis (AG) or burning mouth syndrome (BMS) are frequently encountered in the oral mucosal disease clinic.
- Trial name
- NCT01931293
- Testing
- Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
- Where
- Taiwan
- Volunteers
- 750 people
- Sponsor
- National Taiwan University Hospital
Sleep Disorders, Circadian Rhythm
The Efficacy of Melatonin in the Burning Mouth Syndrome
Burning mouth ( BMS) syndrome is the oral disorder characterized by an intraoral burning sensation for which no medical or dental cause can be found.
- Trial name
- BMS (NCT03788733)
- Testing
- Melatonin 3 mg
- Where
- Spain
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Universidad de Murcia
Burning Mouth Syndrome
Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
What affect does the use of a mucoadhesive drug delivery system (Mucolox®) compounded with clonazepam have in the treatment of burning mouth syndrome? There are no clinical trials reported in the literature that evaluate the use…
- Trial name
- NCT02690844
- Testing
- Clonazepam mixed with Mucolox®, Mucolox® alone, Clonazepam
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Alberta
Burning Mouth Syndrome, Oral Mucosa Disease
Head Yuanshi Dian Therapy in Burning Mouth Syndrome
Burning mouth syndrome is one of the most common oral mucosal diseases in clinic. It is a chronic pain syndrome with extensive burning pain of oral mucosa as its main symptoms.
- Trial name
- NCT04481841
- Testing
- oryzanol + vitamin B2 (riboflavin) + vitamin E
- Where
- 3 sites in China
- Volunteers
- 290 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Stomatitis, Pain
MucoLock™ for Treatment of Stomatitis
The purpose of this research is to test how well people can tolerate MucoLock™ as a treatment for mouth pain or burning sensation and how well it works to reduce mouth pain or burning sensation.
- Conditions
- Stomatitis, Pain, Burning Mouth, Burning Mouth Syndrome
- Trial name
- NCT07506018
- Testing
- MucoLock Oral Gel
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Baptist Health South Florida
Burning Mouth Syndrome
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
The aim of this study was to report the effect of laser diode on the treatment of burning mouth syndrome (BMS) Patients were randomly allocated to two different groups: the first one (group A) underwent Laser diode whereas the…
- Trial name
- laser (NCT02757612)
- Testing
- laser diode
- Where
- Spain
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Universidad de Murcia
Burning Mouth Syndrome, Progesterone
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
The aim of this study was to determine the level of salivary estradiol, progesterone and dehydroepiandrosterone in female postmenopausal women with and without burning mouth syndrome.
- Conditions
- Burning Mouth Syndrome, Progesterone, Dehydroepiandrosterone, Quality of Life
- Trial name
- NCT04535973
- Testing
- unstimulated saliva sample for hormone analysis, quality of life questionnaire
- Where
- Croatia
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Zagreb
Burning Mouth Syndrome
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
Burning mouth syndrome (BMS) is a syndrome characterized by burning and persistent oral pain, ranging from mild to intense, in the absence of organic disorders of the oral cavity and with a major impact on the quality of life of…
- Trial name
- NCT05872789
- Testing
- Diazepam 1% oral gel
- Where
- Italy
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Catania
Primary Burning Mouth Syndrome (BMS)
Theravex® for Burning Mouth Syndrome
In this randomized, double-blind, placebo-controlled trial, 116 adults with primary BMS were assigned (1:1) to receive THERAVEX® Total Oral Care Plus or placebo for 8 weeks.
- Trial name
- NCT07564843
- Testing
- THERAVEX® Total Oral Care Plus
- Where
- Egypt
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- Biointelligent Technology Systems SL
Burning Mouth Syndrome
Botulinum Toxin in Burning Mouth Syndrome
The effect of botulinum neurotoxin type A intradermal injection in will be evaluated in 4 patients with clinical diagnosis of burning mouth syndrome involving the anterior two-thirds of the tongue and the lower lip for at least 6…
- Trial name
- NCT02964728
- Testing
- Botulinum Neurotoxin Type A, Normal saline
- Volunteers
- 6 people
- Sponsor
- Presidio Ospedaliero Garibaldi-Centro